Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • clinical trials
  • Page 2

Tag: clinical trials

  • BiotechToday
  • World

WILL COVID-19 VACCINE WORK?

bioxone October 31, 2020October 30, 2020 1

Chitra Roy, University of Calcutta As we are getting closer to the COVID-19 vaccine, it is exciting to think of the day when the virus will be gone. But, the COVID-19 vaccine will not be the magic bullet considering its efficacy and the challenges currently being faced in these efficacy studies. Efficacy of a vaccine […]

Read More
  • BiotechToday
  • World

Witnessing rays of hope as the first Ebola treatment wins approval by FDA

bioxone October 19, 2020October 19, 2020

Surupa Chakraborty, Amity University Kolkata The U.S. Food and Drug Administration recently approved Inmazeb, a potent treatment involving a cocktail of three lab-made monoclonal antibodies (atoltivimab, maftivimab, and odesivimab-ebgn) to fight against Ebola, one of the world’s deadliest diseases known so far. Inmazeb targets the glycoprotein, which latches onto the cell surface receptors and fuses […]

Read More
  • BiotechToday
  • World

CRISPR unlocks its potential to diagnose Covid-19 within 5 minutes

bioxone October 11, 2020October 10, 2020

-Surupa Chakraborty, Amity University Kolkata A new CRISPR based test that can diagnose the coronavirus infection within few minutes, joins the race of speedy detection after RT-PCR, rapid testing, and FELUDA test. The potent applications of CRISPR have been talked about for many years now. It is best known for its ability to seek out […]

Read More
  • Biotechnopedia
  • DNA-Tales

Is Optogenetics a promising approach for Bionic vision restoration?

bioxone September 28, 2020September 28, 2020 2

-Sayanti Pal, Amity University Kolkata Retinal Degeneration is a condition in which there is a slow degeneration of the retinal cells, eventually leading to blindness. People who suffer from these retinal degenerative diseases for years are said to suffer from permanent loss of vision. But thanks to recent advances in science and technology for giving us […]

Read More

Posts navigation

1 2

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy